Concepedia

Mário Mariz

MM

2

Publications

103

Citations

2

H-Index

2009

Active since

Affiliations

Hospital Clínic de Barcelona(Current)

Clinica Universidad de Navarra

Mário Mariz is an author at Hospital Clínic de Barcelona specializing in health sciences, oncology, and hematology.

Top concepts

Publications per year

2009–2020

2

Publications

2

Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study

Jacob P. Laubach, Fredrik Schjesvold, Mário Mariz et al. · The Lancet Oncology · 2020 · 67 citations

, , +8

Multicenter, Randomized, Open-Label, Phase III Trial of Lenalidomide-Dexamethasone (Len/dex) Vs Therapeutic Abstention in Smoldering Multiple Myeloma at High Risk of Progression to Symptomatic MM: Results of the First Interim Analysis.

María‐Victoria Mateos, Lucía López‐Corral, Miguel‐Teodoro Hernández et al. · Blood · 2009 · 36 citations

Rows per page

1–2 of 2